Ephedra “Template” Will Increase Scrutiny Of Labeling, AERs – Israelsen
This article was originally published in The Tan Sheet
Executive Summary
FDA's ban of ephedrine alkaloid-containing dietary supplements will have a definitive impact on supplement labeling going forward, according to Utah Natural Products Alliance Executive Director Loren Israelsen